MYIBDDiet app to help adults with IBD manage their diet
Official title: A Pilot Randomized Trial Investigating the MyIBDDiet App to Improve Self-management of an Anti-inflammatory Diet for Individuals With Inflammatory Bowel Disease
Run by University of Alberta · NCT06683105 · Data updated 2026-11-12
This project will test if the MYIBDDiet app helps adults with inflammatory bowel disease learn about and follow healthier eating over one month.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | March 15, 2026 |
| Main results expected | December 1, 2028 |
| Study ends | June 1, 2029 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT06683105 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with an established diagnosis of Crohn's disease or ulcerative colitis who are not in an acute flare, not pregnant, able to consent and use a smartphone app, and without conditions requiring special diets are ideal candidates.
✕Probably not a fit
Patients with short bowel syndrome, high ostomy output, intestinal strictures, malnutrition, pregnancy or breastfeeding, active malignancy, other conditions requiring dietary restriction, or those already on a therapeutic or IBD-specific diet are excluded and unlikely to benefit from this app.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional comparison assigns adults with IBD who are not in an acute flare to use the MYIBDDiet smartphone app or receive standard diet information. Participants in the app arm will use it daily for one month and both groups will complete surveys on usability, nutrition knowledge, and self-reported dietary changes. Key outcomes include ease of use, usefulness for learning about healthy eating, and short-term changes in dietary behavior. The trial excludes people with conditions requiring specific dietary restrictions, malnutrition, or active malignancy.
Why it matters
Potential benefit: If successful, the app could make it easier for people with IBD to learn and stick to dietary advice, improving nutrition and daily symptom management.
How similar studies have gone: While dietary approaches such as the Mediterranean diet have shown benefits in IBD and digital education has worked in other chronic diseases, direct evidence for app-based diet self-management in IBD is limited and this approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥18 years 2. Able to provide informed consent 3. Established diagnosis of IBD determined by treating physician 4. Not in acute flare 5. Not pregnant 6. Willing and able to comply with all required study procedures Exclusion Criteria: 1. Short bowel syndrome 2. High ostomy output 3. Intestinal strictures 4. Pregnancy or breastfeeding 5. Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) ) 6. Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis) 7. Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis. 8. Currently on a therapeutic diet 9. Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet) 10. Active malignancy
Where it's running
-
Zeidler Ledcor Centre, University of Alberta
Edmonton, Alberta, Canada Recruiting
Study contacts
- Study coordinator: Karen Wong, MD, FRCPC
- Email: kwong3@ualberta.ca
- Phone: 780-492-8691
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
Moderate breathing and movement: Can regular exercise help people with quiescent inflammatory bowel disease feel better?
This trial tests whether a moderate-intensity exercise program improves quality of life for adults with Crohn's disease or ulcerative colitis who are currently in clinical remission.
-
Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis in Remission
This study tests whether a Mediterranean diet, with or without an 8-hour eating window, helps gut health and quality of life in adults with ulcerative colitis in remission.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease
This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.
-
PVT401 in healthy adults
This trial will test intravenous PVT401 in healthy adults who carry the HLA DRB4*0101 or DRB4*0103 allele to see how the drug behaves in the body and whether single and multiple doses are safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.